PRELUDE CAPITAL MANAGEMENT, LLC - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 85 filers reported holding ACORDA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 40.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$5,000
-58.3%
6,353
+742.6%
0.00%
-100.0%
Q4 2018$12,000
+9.1%
754
+33.2%
0.00%0.0%
Q3 2018$11,000
-74.4%
566
-68.6%
0.00%
-66.7%
Q1 2018$43,000
-41.1%
1,800
-47.1%
0.00%
-50.0%
Q4 2017$73,000
-12.0%
3,400
-2.9%
0.01%
-14.3%
Q3 2017$83,000
-58.3%
3,500
-65.3%
0.01%
-63.2%
Q2 2017$199,000
-9.1%
10,100
-3.3%
0.02%
-9.5%
Q1 2017$219,000
-35.8%
10,443
-42.5%
0.02%
-48.8%
Q4 2016$341,000
+19.2%
18,152
+61.8%
0.04%
+2.5%
Q2 2016$286,000
+472.0%
11,219
+490.5%
0.04%
+471.4%
Q1 2016$50,000
-25.4%
1,900
-5.0%
0.01%
-22.2%
Q2 2015$67,000
+42.6%
2,000
+42.9%
0.01%
+28.6%
Q1 2015$47,000
-76.0%
1,400
-70.8%
0.01%
-75.9%
Q4 2014$196,000
+20.2%
4,8000.0%0.03%
+26.1%
Q3 2014$163,000
+27.3%
4,800
+26.3%
0.02%
+35.3%
Q2 2014$128,000
+40.7%
3,800
+58.3%
0.02%
+41.7%
Q1 2014$91,000
-40.5%
2,400
-54.2%
0.01%
-52.0%
Q4 2013$153,000
-15.9%
5,243
-1.3%
0.02%
-13.8%
Q3 2013$182,000
-58.1%
5,313
-59.6%
0.03%
-68.8%
Q2 2013$434,000
-54.3%
13,159
-55.6%
0.09%
-47.5%
Q1 2013$950,00029,6590.18%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 325,000$8,289,0002.39%
ARMISTICE CAPITAL, LLC 232,000$5,917,0002.25%
SENZAR ASSET MANAGEMENT, LLC 358,191$9,135,662,0001.99%
SCOPIA CAPITAL MANAGEMENT LP 3,171,229$80,882,0001.67%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,029,410$26,255,0001.03%
Baker Brothers Advisors 3,661,082$93,376,0000.98%
ARBOR CAPITAL MANAGEMENT LLC 58,783$1,499,0000.79%
Spark Investment Management LLC 292,400$7,457,0000.70%
SPHERA FUNDS MANAGEMENT LTD. 98,000$2,499,0000.65%
Virtus ETF Advisers LLC 21,130$539,0000.40%
View complete list of ACORDA THERAPEUTICS INC shareholders